A2 Corp, which markets milk products with a protein variant claimed to have health benefits, has indicated its capital structure is under review as the company considers growth opportunities.
The shares had been halted from trading pending a statement after a media report that it was seeking to raise as much as $200 million.
"Any review of the company and its balance sheet would clearly indicate that the sums recently speculated are significantly in excess of what the company or the market can or would contemplate," managing director Geoffrey Babidge says in a statement today.
A2 "continues to assess the company's optimal capital structure in light of its growth opportunities, including new opportunities that may emerge".
The shares climbed 1.5% to 68 cents when they resumed trading on the NZX, valuing the company at $411 million. The stock has more than doubled in the past 12 months.
In the year ended June 30, A2 raised a total of $7.7 million in equity capital, including $5.18 million in March in a share placement to AMP Capital Investors (New Zealand).
As at June 30 it had cash on hand of $6.6 million while holding to a strategy of carrying "little or no net debt whilst in a rapid expansion phase".
Last month, in announcing the results of a strategic review, the company confirmed it would continue to be "capital light," relying on partnerships to drive its growth into new dairy markets and categories.
The statement today reiterated last week's announcement that the company is in talks with the NZX about shifting its listing to the main board from the NZAX, a market for smaller companies and start-ups.
"A move to the NZX main board may provide greater liquidity and increase access to capital," Mr Babidge said last week.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Xero directors Drury, Winkler and Morgan cash in on 35% share price rally
- iPredict closing down due to money laundering risk
- Serco's prison report challenge: Hide and Davis go head-to-head
- MARKET CLOSE: NZ shares mixed; Spark, Fletcher join Asian rally, Xero drops as Drury trims stake
- Tech expert's complaint about 'snake oil' ad upheld
Most listened to
- “A very ballsy thing to do” – Rodney Hide and Kelvin Davis discuss Serco’s response to Correction’s Mt Eden Prison report
- “The response from shareholders has been overwhelming” — A2 Corporation chief executive Geoff Babidge
- Greg Gent says a board of 13 people is "prehistoric"
- Arvida CEO Bill McDonald on his company's half-year net profit
- Lance Wiggs on the future of food exports
- Auckland Councillor Chris Darby on the Council's alternative funding report
- Nevil Gibson discusses his latest Editor's Insight on oil prices
- Campbell Gibson, Nick Grant and Chelsea Armitage chat about the inner workings of New Zealand media
- Paul Brislen discusses the 'snake oil' sales tactics of SalesConcepts
- Fonterra chief executive Theo Spierings reveals his ambitious China plan
- UDC Finance chief executive Wayne Percival talks about the company's profit
- Hamish McNicol discusses the latest court stories